Stocks showed mixed results as the market pauses after record highs. UnitedHealth's gains boost the Dow, while inflation concerns weigh on the S&P 500 and Nasdaq. What’s next for investors?
Astronomers have found the most distant black hole yet, CAPERS-LRD-z9, weighing 300 million solar masses just 500 million years after the Big Bang. This discovery sheds light on ancient celestial objects and pushes the boundaries of cosmic exploration.
As U.S. stocks ended the week with mixed results, the Michigan Consumer Sentiment Index revealed a drop in economic confidence. UnitedHealth saw a surge after Berkshire Hathaway increased its stake, while Sunrun soared on strong earnings. Get the full market recap!
U.S. equities experienced a mixed performance at midday, with retail sales showing strong consumer spending. While the Dow slightly rose, the S&P 500 and Nasdaq fell, driven by varying performances from major stocks including UnitedHealth and Salesforce.
S&P 500 futures are nearly flat after a record close, while UnitedHealth jumps over 9% thanks to investments from Buffett and Burry. What's next for the market as economic indicators loom?
Despite a disappointing inflation report causing most stocks to fall, gains in Big Tech, particularly Amazon, helped to soften the blow on Wall Street as the S&P 500 reached another all-time high.
In a surprising move, the US Department of Health has canceled contracts worth $500 million related to mRNA vaccine research, sparking concerns about future pandemic preparedness and the direction of vaccine technology.
Samsung has launched the Odyssey OLED G6, the first 500Hz OLED gaming monitor. Priced at $1,000, it features stunning visuals and rapid response times, catering to serious gamers looking for top performance.
U.S. stock futures rise as the S&P 500 and Nasdaq hit record highs, fueled by positive inflation data and expectations of a Federal Reserve rate cut. Will this momentum continue?
HHS Secretary Robert F. Kennedy Jr. has sparked outrage by canceling $500 million in mRNA vaccine research grants, citing questionable data. Experts warn this could hinder public health efforts and the future of vaccine technology.
